Platelet adenine nucleotides and arachidonic acid metabolism in the myeloproliferative disorders.

[1]  D. Deykin,et al.  Platelet arachidonic acid metabolism and platelet function in ten patients with chronic myelogenous leukemia. , 1980, Blood.

[2]  M. Okuma,et al.  Altered arachidonate metabolism by platelets in patients with myeloproliferative disorders. , 1979, Blood.

[3]  A. Nurden,et al.  Detection of an Acquired Platelet Storage Pool Disease in Three Patients with a Myeloproliferative Disorder , 1979, Thrombosis and Haemostasis.

[4]  P. Cuatrecasas,et al.  Regulation of arachidonate metabolism via lipoxygenase and cyclo-oxygenase by 12-HPETE, the product of human platelet lipoxygenase. , 1979, Biochemical and biophysical research communications.

[5]  D. Deykin,et al.  The use of high pressure liquid chromatography (HPLC) for the separation of radiolabeled arachidonic acid and its metabolites produced by thrombin-treated human platelets. II. Establishment of optimal assay conditions. , 1979, Prostaglandins.

[6]  H. Ibayashi,et al.  Abnormalities of Platelet Adenine Nucleotides in Patients with Myeloproliferative Disorders , 1979, Thrombosis and Haemostasis.

[7]  N. Russell,et al.  Thrombocytopathy in Preleukaemia: Association with a Defect of Thromboxane A2 Activity , 1979, British journal of haematology.

[8]  J. White,et al.  Platelet Storage Pool Deficiency and Prostaglandin Synthesis in Chronic Granulocytic Leukaemia , 1978, British journal of haematology.

[9]  A. Schafer,et al.  Platelet resistance to prostaglandin D2 in patients with myeloproliferative disorders , 1978 .

[10]  A. Sedar,et al.  Hereditary abnormality of platelet aggregation attributable to nucleotide storage pool deficiency. , 1978, Blood.

[11]  J. Simon.  A radioimmunoassay for 6-keto- prostaglandin F1α , 1978 .

[12]  M. Lagarde,et al.  Impairment of Platelet Thromboxane A2 Generation and of the Platelet Release Reaction in Two Patients with Congenital Deficiency of Platelet Cyclo‐oxygenase , 1978, British journal of haematology.

[13]  R. Hardisty,et al.  Disorders of platelet function. , 1977, British medical bulletin.

[14]  H. Weiss,et al.  POSSIBLE CONGENITAL DEFECT IN PLATELET THROMBOXANE SYNTHETASE , 1977, The Lancet.

[15]  A. Makheja,et al.  Differential separation of thromboxanes from prostaglandins by one and two-dimensional thin layer chromatography. , 1977, Prostaglandins.

[16]  J. Wharton,et al.  Defective Platelet Lipid Peroxidation in Myeloproliferative Disorders: A Possible Defect of Prostaglandin Synthesis , 1977, British journal of haematology.

[17]  H. White,et al.  Biochemical properties of the prostaglandin/thromboxane synthetase of human blood platelets and comparison with the synthetase of bovine seminal vesicles. , 1976, Prostaglandins.

[18]  J. Mustard,et al.  Sodium arachidonate can induce platelet shape change and aggregation which are independent of the release reaction. , 1976, Science.

[19]  R. Graham,et al.  The platelet defect in leukemia. Platelet ultrastructure, adenine nucleotide metabolism, and the release reaction. , 1975, The Journal of clinical investigation.

[20]  M. Hamberg,et al.  Physiological role of an endoperoxide in human platelets: hemostatic defect due to platelet cyclo-oxygenase deficiency. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Nugteren.  Arachidonate lipoxygenase in blood platelets. , 1975, Biochimica et biophysica acta.

[22]  J. Smith,et al.  Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction. , 1974, The Journal of clinical investigation.

[23]  H. Jacob,et al.  Abnormalities of platelet function in the myeloproliferative disorders. , 1972, JAMA.

[24]  E. Mürer.  Release reaction and energy metabolism in blood platelets with special reference to the burst in oxygen uptake. , 1968, Biochimica et biophysica acta.

[25]  B. Johnson,et al.  Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems. , 1966, Analytical biochemistry.

[26]  A. Guarini,et al.  Acquired Storage Pool Disease in Myeloproliferative Disorders , 1979, Thrombosis and Haemostasis.

[27]  Gerrard Jm,et al.  Prostaglandins and thromboxanes: "middlemen" modulating platelet function in hemostasis and thrombosis. , 1978 .

[28]  D. Handley,et al.  Platelet function in essential thrombocythaemia , 1975 .